Biotech drug companies rose after hepatitis C and HIV drug maker Gilead Sciences agreed to buy cancer drug maker Kite Pharma for $11.9 billion.
News
- Stocks are mixed as storm affects insurers, energy companies
- Markets Right Now: Stocks finish mixed in quiet trading
Stocks are finishing little changed on a quiet day of trading as health care companies rise and energy and insurance companies slip. Biotech drug ...
- Gilead to pay $11.9B for cancer treatment developer Kite
The deal helps establish Gilead as a leader in so-called cellular therapy, the biotechnology company's president and CEO John F. Milligan said in a ...
- Texas Power Brokers: Republican Rep. Will Hurd
And also we can't forget, around biomedical sciences. You have a lot of companies in the biomedical tech space being created here in San Antonio.
- UTRGV gets green light to seek two new doctorate degrees
The Doctorate of Philosophy in Cellular, Molecular and Biomedical Science is intended to be an interdisciplinary ... the Rio GrandeValley, Bailey said, with the closest similar program being offered in Houston, Austin or San Antonio.